Masimo Corporation
52 Discovery
Irvine, CA 92618, USA
Tel.: 949-297-7000
Fax.: 949-297-7001
www.masimo.com
3149433
MEDICAL ELECTRICAL EQUIPMENT
WITH RESPECT TO ELECTRIC SHOCK, FIRE AND MECHANICAL
HAZARDS ONLY IN ACCORDANCE WITH
ANSI/AAMI ES 60601-1:2005, CAN/CSA C22.2 No. 60601-1:2008, and
applicable Particular (EN/ISO 80601-2-61:2011) and related Collateral (IEC
60601-1-8:2006) Standards for which the product has been found to comply
by Intertek.
For Sale in the USA
These operating instructions provide the necessary information for proper operation of all
models of the Rad-67. There may be information provided in this manual that is not
relevant for your system. General knowledge of pulse oximetry and an understanding of the
features and functions of Rad-67 are prerequisites for its proper use. Do not operate Rad-67
without completely reading and understanding these instructions.
Note: Cleared Use Only: The device and related accessories are cleared by the Food and
Drug Administration (FDA) and are CE Marked for noninvasive patient monitoring and may
not be used for any processes, procedures, experiments, or any other use for which the device
is not intended or cleared by the applicable regulatory authorities, or in any manner
inconsistent with the directions for use or labeling.
Notice: Purchase or possession of this device does not carry any express or implied license
to use with replacement parts which would, alone or in combination with this device, fall
within the scope of one of the relating patents.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Wireless Radio
FCC ID: VKF-MWM1 Model Rad-67 IC: 7362A-MWM1 IC Model: MWM1
EU authorized representative for Masimo Corporation:
®, Adaptive Probe Off Detection®, APOD®, Masimo®, Pulse CO-Oximeter®, rainbow®,
SET®, Signal Extraction Technology®, Signal IQ®, SpHb®, and X-Cal™ are federally
registered trademarks of Masimo Corporation.
Rad-67™ is a trademark of Masimo Corporation. All other trademarks and registered
trademarks are property of their respective owners.
Index -------------------------------------------------------------------------------------------------------- 99
www.masimo.com 5 Masimo
About This Manual
This manual explains how to set up and use Rad-67™ Pulse CO-Oximeter®. Important safety
information relating to general use of Rad-67 appears in this manual. Read and follow any
warnings, cautions, and notes presented throughout this manual. The following are
explanations of warnings, cautions, and notes.
A warning is given when actions may result in a serious outcome (for example, injury, serious
adverse effect, death) to the patient or user.
WARNING: This is an example of a warning statement.
A caution is given when any special care is to be exercised by the patient or user to avoid
injury to the patient, damage to this device, or damage to other property.
CAUTION: This is an example of a caution statement.
A note is given when additional general information is applicable.
Note: This is an example of a note.
www.masimo.com 7 Masimo
Product Description, Features and
Indications for Use
Product Description
The Rad-67™ Pulse CO-Oximeter® is a non-invasive device intended to measure functional
oxygen saturation of arterial hemoglobin (SpO2), pulse rate (PR), and perfusion index (Pi),
along with optional non-invasive measurement of total hemoglobin (SpHb®).
The following key features are available for Rad-67:
Masimo® SET® and rainbow® SET technology performance.
SpO
Spot-Check monitoring of total hemoglobin (SpHb).
Wireless radio for transfer of parameter data.
Indications for Use
The Masimo Rad-67™ Pulse CO-Oximeter® and Accessories are intended for use in clinical
and non-clinical settings.
The Masimo Rad-67™ Pulse CO-Oximeter® and Accessories are indicated for non-invasive
spot-check monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and
pulse rate (PR) for adult and pediatric patients who are well or poorly perfused during both
motion and no motion conditions.
The Masimo Rad-67™ Pulse CO-Oximeter® and Accessories are indicated for non-invasive
spot-check monitoring of total hemoglobin concentration (SpHb) for adult patients.
and pulse rate measuring in motion and low perfusion environments.
2
Contraindications
The Rad-67 is not intended for use as an apnea monitor.
The Rad-67 is not intended to measure hemoglobin (SpHb) on pregnant women.
www.masimo.com 9 Masimo
Safety Information, Warnings and
Cautions
CAUTION: Rad-67 is to be operated by, or under the supervision of, qualified personnel only.
Read the manual, accessories directions for use, all precautionary information, and
specifications before use.
Safety Warnings and Cautions
WARNING: Do not use Rad-67 if it appears or is suspected to be damaged. Damage to the
device can result in exposed electrical circuits that may cause patient harm.
WARNING: Do not adjust, repair, open, disassemble, or modify the Rad-67. Damage to the
device may result in degraded performance and/or patient injury.
WARNING: Do not start or operate the Rad-67 unless the setup was verified to be correct.
Improper set-up of this device may result in degraded performance and/or patient injury.
WARNING: Do not place the Rad-67 or accessories in any position that might cause it to fall
on the patient.
WARNING: Only use Masimo authorized devices with Rad-67. Using unauthorized devices
with Rad-67 may result in damage to the device and/or patient injury.
WARNING: All sensors and cables are designed for use with specific devices. Verify the
compatibility of the device, cable, and sensor before use; otherwise degraded performance
and/or patient injury can result.
WARNING: Do not use the Rad-67 in the presence of flammable anesthetics or other
flammable substance in combination with air, oxygen-enriched environments, or nitrous
oxide to avoid risk of explosion.
WARNING: Do not use the Rad-67 during magnetic resonance imaging (MRI) or in an MRI
environment.
WARNING: Rad-67 may be used during defibrillation. However, to reduce the risk of electric
shock, the operator should not touch the Rad-67 during defibrillation.
WARNING: To protect against electrical shock injury, follow the directions below:
Avoid placing the device on surfaces with visible liquid spills.
Do not soak or immerse the device in liquids.
Do not attempt to sterilize the device.
Use cleaning solutions only as instructed in this Operator's Manual.
Do not attempt to clean the Rad-67 while monitoring patient.
WARNING: To ensure safety, avoid placing anything on the device during operation.
WARNING: As with all medical equipment, carefully route patient cables to reduce the
possibility of patient entanglement or strangulation.
CAUTION: Do not place the Rad-67 where the controls can be changed by the patient.
CAUTION: Do not place Rad-67 where the AC power supply cannot be readily disconnected
when used on AC power.
www.masimo.com 11 Masimo
Rad-67 Safety Information, Warnings and Cautions
CAUTION: To ensure patient electrical isolation, all external device connections to the
output interface port must be done using only authorized data cables.
Note: Disconnect the device from AC mains by unplugging the AC power supply from the
Rad-67.
Note: Use and store the Rad-67 in accordance with specifications. See the Specifications
section in this manual.
Performance Warnings and Cautions
WARNING: Rad-67 is intended for spot-check monitoring only, no physiological alarms are
provided.
WARNING: Rad-67 should not be used as the sole basis for medical decisions. It must be
used in conjunction with clinical signs and symptoms.
WARNING: Do not utilize SpHb spot-check measurements as the sole basis for clinical
decisions on blood transfusions. The SpHb spot-check accuracy range does not include
values below 8 g/dL, which may be important for determining the need for transfusions.
WARNING:If any measurement seems questionable, first check the patient’s vital signs by
alternate means and then check Rad-67 for proper functioning.
WARNING: SpHb is not intended for use in pediatrics, pregnant patients, and patients with
renal disease.
WARNING: Variation in hemoglobin measurements may be profound and may be affected
by sample type, body positioning, as well as other physiological conditions. Any results
exhibiting inconsistency with the patient's clinical status should be repeated and/or
supplemented with additional data. Blood samples should be analyzed by laboratory
instruments prior to clinical decision making to completely understand the patient’s
condition.
WARNING: Rad-67 should not be used as a replacement or substitute for ECG-based
arrhythmia analysis.
WARNING: Rad-67 may be used during defibrillation. This may affect the accuracy or
availability of the parameters and measurements.
WARNING: Rad-67 may be used during electrocautery. This may affect the accuracy or
availability of the parameters and measurements.
WARNING: Properly apply sensors according to sensor's directions for use. Misapplied
sensor or sensors that become partially dislodged may cause no or incorrect readings.
WARNING: Select a well perfused site for monitoring, very low perfusion at the monitored
site may result in no or incorrect readings.
WARNING: Do not use Rad-67 on patients that have been injected with dyes or any
substance containing dyes, the change in usual blood pigmentation may cause no or
incorrect readings.
WARNING: Displayed parameter(s) may not be accurate when a low SIQ message is
provided. Clinicians should consider additional information to supplement values to
completely understand the patient’s condition.
WARNING: If SpO2 values indicate hypoxemia, a laboratory blood sample should be taken to confirm the patient’s condition.
www.masimo.com 12 Masimo
Rad-67 Safety Information, Warnings and Cautions
WARNING: Optical, pleth-based measurements (e.g. SpO2 and SpHb) can be affected by the
following:
Improper sensor application or use of use of incorrect sensor.
Blood pressure cuff applied to the same arm as the sensor site.
Intravascular dyes such as indocyanine green or methylene blue.
Venous congestion.
Abnormal venous pulsations (e.g. tricuspid value regurgitation, Trendelenburg
position).
Abnormal pulse rhythms due to physiological conditions or induced through
synthesis disorders (quantitative defects such as Thalassemias).
Severe anemia.
CAUTION: If using Rad-67 during full body irradiation, keep the sensor out of the radiation
field. If the sensor is exposed to the radiation, the reading might be inaccurate or the device
might read zero for the duration of the active irradiation period.
www.masimo.com 13 Masimo
Rad-67 Safety Information, Warnings and Cautions
CAUTION: When patients are undergoing photodynamic therapy they may be sensitive to
light sources. Pulse oximetry may be used only under careful clinical supervision for short
time periods to minimize interference with photodynamic therapy.
CAUTION: High ambient light sources such as surgical lights (especially those with a xenon
light source), bilirubin lamps, fluorescent lights, infrared heating lamps, and direct sunlight
can interfere with the performance of the sensor.
CAUTION: To prevent interference from ambient light, ensure that the sensor is properly
applied, and cover the sensor site with opaque material, if required. Failure to take this
precaution in high ambient light conditions may result in inaccurate measurements.
CAUTION: When using a compatible sensor, ensure the gender has been entered correctly.
Entering an incorrect gender may affect measurement performance of the device.
CAUTION: If the Low Perfusion message is frequently displayed, find a better perfused
monitoring site. In the interim, assess the patient and, if indicated, verify oxygenation
status through other means.
CAUTION: To minimize radio interference, other electrical equipment that emits radio
frequency transmissions should not be in close proximity to Rad-67.
CAUTION: Do not place the Rad-67 near electrical equipment that may affect the device,
preventing it from working properly.
CAUTION: Failure to charge Rad-67 promptly after a Low Battery alarm may result in the
device shutting down.
CAUTION: Do not connect the AC power supply to an electrical outlet controlled by a wall
switch or dimmer.
CAUTION: In order to establish and maintain Rad-67’s minimum Quality of Service, the
following network specifications should be met before and after installation:
Wired Network Connection
During Ping Test, passing result if:
a. At least 98% of packets have latency ≤ 30 milliseconds, and
b. No more than 2 % packets loss.
Wireless Network Connection
During Ping Test, passing result if:
a. At least 98% of packets have latency ≤ 100 milliseconds,
b. No more than 2 % packets loss, and
c. Primary access point signal strength at least -67 dBm.
CAUTION: The wireless quality of services may be influenced by the presence of other
devices that may create radio frequency interference (RFI). Some RFI devices to consider are
as follows: electrocautery equipment, cellular telephones, wireless PC and tablets, pagers,
RFID, MRI electrically powered wheelchair, etc. When used in the presence of potential RFI
devices, consideration should be taken to maximize separation distances and to observe for
any potential signs of interference such as loss of communication or reduced Wi-Fi signal
strength.
CAUTION: Replace the cable or sensor when a replace sensor or when a low SIQ message is
consistently displayed while monitoring consecutive patients after completing the low SIQ
troubleshooting steps listed in the troubleshooting section.
www.masimo.com 14 Masimo
Rad-67 Safety Information, Warnings and Cautions
Note: Cables and sensors are provided with X-Cal™ technology to minimize the risk of
inaccurate readings and unanticipated loss of patient monitoring. Refer to the Cable or
Sensor Directions for Use for the specified duration of patient monitoring time.
Note: Physiological conditions that result in loss of pulsatile signal may result in no SpO2 or
SpHb readings.
Note: Rad-67 is provided with a Wi-Fi signal indicator as an indication of Wi-Fi
communication.
Note: Always charge Rad-67 when it is not in use to ensure that the battery remains fully
charged.
Note: All batteries lose capacity with age, thus the amount of run time at Low Battery will
vary depending upon the age of the Battery Module.
Note: A functional tester cannot be used to assess the accuracy of Rad-67.
Note: When using the Maximum Sensitivity setting, performance of the "Sensor Off"
detection may be compromised. If the Rad-67 is in this setting and the sensor becomes
dislodged from the patient, the potential for false readings may occur due to environmental
"noise" such as light, vibration, and excessive air movement.
Note: Additional information specific to the Masimo sensors compatible with Rad-67,
including information about parameter/measurement performance during motion and low
perfusion, may be found in the sensor's directions for use (DFU).
Cleaning and Service Warnings and Cautions
WARNING: Do not attempt to remanufacture, recondition or recycle the Rad-67 as these
processes may damage the electrical components, potentially leading to patient harm.
WARNING: To avoid electric shock, do not attempt to replace or remove the Battery from
the Rad-67. Service of Rad-67 should be done by qualified personnel only.
CAUTION: Only perform maintenance procedures specifically described in the manual.
Otherwise, return the Rad-67 for servicing.
CAUTION: Do not touch, press, or rub the display panels with abrasive cleaning compounds,
instruments, brushes, rough-surface materials, or bring them into contact with anything
that could scratch the display.
CAUTION: To avoid permanent damage to the Rad-67, do not use undiluted bleach (5% -
5.25% sodium hypochlorite) or any other cleaning solution not recommended.
CAUTION: Do not use petroleum-based or acetone solutions, or other harsh solvents, to
clean the Rad-67. These substances affect the device’s materials and device failure can
result.
CAUTION: Do not submerge the Rad-67 in any cleaning solution or attempt to sterilize by
autoclave, irradiation, steam, gas, ethylene oxide or any other method. This will seriously
damage the device.
CAUTION: To prevent damage, do not soak or immerse Rad-67 in any liquid solution.
Compliance Warnings and Cautions
WARNING: Any changes or modifications not expressly approved by Masimo shall void the
warranty for this equipment and could void the user’s authority to operate the equipment.
www.masimo.com 15 Masimo
Rad-67 Safety Information, Warnings and Cautions
WARNING: In accordance with international telecommunication requirements, the
frequency band of 2.4 GHz and 5.15 to 5.25 GHz is only for indoor usage to reduce potential
for harmful interference to co-channel mobile satellite systems.
WARNING: Per RSS-Gen, Section 8.4 This device complies with Industry Canada licenseexempt RSS standard(s). Operation is subject to the following two conditions: (1) this
device may not cause interference, and (2) this device must accept any interference,
including interference that may cause undesired operation of the device. Per RSS-Gen, Radio
apparatus shall comply with the requirements to include required notices or statements to
the user of equipment with each unit of equipment model offered for sale.
CAUTION: Disposal of Product: Comply with local laws in the disposal of the device and/or
its accessories.
CAUTION: Device contains an internal battery. Dispose of the battery according to required
country or regional requirements.
Note: Use Rad-67 in accordance with the Environmental Specifications section in the
Operator's Manual.
Note: This device complies with part 15 of the FCC Rules. Operation is subject to the
following two conditions: (1) This device may not cause harmful interference, and (2) this
device must accept any interference received, including interference that may cause
undesired operation.
Note: This equipment has been tested and found to comply with the limits for a Class B
digital device, pursuant to part 15 of the FCC Rules. These limits are designed to provide
reasonable protection against harmful interference in a residential installation. This
equipment generates, uses and can radiate radio frequency energy and, if not installed and
used in accordance with the instructions, may cause harmful interference to radio
communications. However, there is no guarantee that interference will not occur in a
particular installation. If this equipment does cause harmful interference to radio or
television reception, which can be determined by turning the equipment off and on, the user
is encouraged to try to correct the interference by one or more of the following measures:
Reorient or relocate the receiving antenna.
Increase the separation between the equipment and receiver.
Connect the equipment into an outlet on a circuit different from that to which
the receiver is connected.
Consult the dealer or an experienced radio/TV technician for help.
Note: This equipment has been tested and found to comply with the Class B limits for
medical devices according to the EN 60601-1-2: 2007, Medical Device Directive 93/42/EEC.
These limits are designed to provide reasonable protection against harmful interference in
all establishments, including domestic establishments.
Note: In order to maintain compliance with FCC regulations, shielded cables must be used
with this equipment. Operation with non-approved equipment or unshielded cables is likely
to result in interference to radio and TV reception. The user is cautioned that changes and
modifications made to the equipment without the approval of manufacturer could void the
user's authority to operate this equipment.
Note: To satisfy RF exposure requirements, this device and its antenna must not be colocated or operating in conjunction with any other antenna or transmitter.
Note: This Class B digital apparatus complies with Canadian ICES-003.
www.masimo.com 16 Masimo
Rad-67 Safety Information, Warnings and Cautions
Note: This device complies with Industry Canada license-exempt RSS standard(s).
Operation is subject to the following two conditions: (1) this device may not cause
interference, and (2) this device must accept any interference, including interference that
may cause undesired operation of the device.
www.masimo.com 17 Masimo
Chapter 1: Technology Overview
The following chapter contains general descriptions about parameters, measurements, and
the technology used by Masimo products.
Signal Extraction Technology® (SET®)
Masimo Signal Extraction Technology's signal processing differs from that of conventional
pulse oximeters. Conventional pulse oximeters assume that arterial blood is the only blood
moving (pulsating) in the measurement site. During patient motion, however, the venous
blood also moves, causing conventional pulse oximeters to read low values, because they
cannot distinguish between the arterial and venous blood movement (sometimes referred to
as noise).
Masimo SET® pulse oximetry utilizes parallel engines and adaptive filtering. Adaptive filters
are powerful because they are able to adapt to the varying physiologic signals and/or noise
and separate them by looking at the whole signal and breaking it down to its fundamental
components. The Masimo SET® signal processing algorithm, Discrete Saturation Transform
(DST®), in parallel with Fast Saturation Transform (FST®), reliably identifies the noise,
isolates it and, using adaptive filters, cancels it. It then reports the true arterial oxygen
saturation for display on the monitor.
Masimo rainbow SET® Parallel Engines
This figure is for conceptual purposes only.
®
www.masimo.com 19 Masimo
Rad-67 Chapter 1: Technology Overview
Masimo SET® DST
This figure is for conceptual purposes only.
General Description for Oxygen Saturation (SpO2)
Pulse oximetry is governed by the following principles:
1. Oxyhemoglobin (oxygenated blood) and deoxyhemoglobin (non-oxygenated
blood) differ in their absorption of red and infrared light (spectrophotometry).
2. The amount of arterial blood in tissue changes with your pulse
(photoplethysmography). Therefore, the amount of light absorbed by the varying
quantities of arterial blood changes as well.
Successful Monitoring for SpO2, PR and Pi
Stability of the SpO2 readings may be a good indicator of signal validity. Although stability
is a relative term, experience will provide a good feeling for changes that are artifactual or
physiological and the speed, timing, and behavior of each.
The stability of the readings over time is affected by the averaging time being used. The
longer the averaging time, the more stable the readings tend to become. This is due to a
dampened response as the signal is averaged over a longer period of time than during
shorter averaging times. However, longer averaging times delay the response of the
oximeter and reduce the measured variations of SpO2 and pulse rate.
Functional Oxygen Saturation (SpO2)
The Rad-67 is calibrated to measure and display functional oxygen saturation (SpO2): the
amount of oxyhemoglobin expressed as a percentage of the hemoglobin that is available to
transport oxygen.
Note: Dyshemoglobins are not capable of transporting oxygen, but are recognized as
oxygenated hemoglobins by conventional pulse oximetry.
www.masimo.com 20 Masimo
Rad-67 Chapter 1: Technology Overview
General Description for Pulse Rate (PR)
Pulse rate (PR), measured in beats per minute (BPM) is based on the optical detection of
peripheral flow pulse.
General Description for Perfusion Index (Pi)
The Perfusion Index (Pi) is the ratio of the pulsatile blood flow to the non-pulsatile or static
blood in peripheral tissue. Pi thus represents a noninvasive measure of peripheral perfusion
that can be continuously and noninvasively obtained from a pulse oximeter.
Signal IQ
The Signal IQ provides an indicator of the assessment of the confidence in the displayed
SpO2 value. The SpO2 SIQ can also be used to identify the occurrence of a patient’s pulse.
With motion, the plethysmographic waveform is often distorted and may be obscured by
noise artifact. Shown as a vertical line, the SpO2 SIQ coincides with the peak of an arterial
pulsation. Even with a plethysmographic waveform obscured by artifact, the Signal IQ
identifies the timing that the algorithms have determined for the arterial pulsation. The
pulse tone (when enabled) coincides with the vertical line of the SpO2 SIQ.
The height of the vertical line of the SpO2 SIQ provides an assessment of the confidence in
the measurement displayed. A high vertical bar indicates higher confidence in the
measurement. A small vertical bar indicates lower confidence in the displayed
measurement. When the Signal IQ is very low, this suggests that the accuracy of the
displayed measurement may be compromised. See About the Status Bar on page 34.
rainbow Pulse CO-Oximetry Technology®
rainbow Pulse CO-Oximetry technology is governed by the following principles:
carboxyhemoglobin (blood with carbon monoxide content), methemoglobin
(blood with oxidized hemoglobin) and blood plasma constituents differ in their
absorption of visible and infrared light (using spectrophotometry).
2. The amount of arterial blood in tissue changes with pulse
(photoplethysmography). Therefore, the amount of light absorbed by the varying
quantities of arterial blood changes as well.
www.masimo.com 21 Masimo
Rad-67 Chapter 1: Technology Overview
1. Light Emitting Diodes
(LEDs)
(7 + wavelengths)
2. Detector
Rad-67 uses a multi-wavelength sensor to distinguish between oxygenated blood,
deoxygenated blood, blood with carbon monoxide, oxidized blood and blood plasma.
Rad-67 utilizes a sensor with various light-emitting diodes (LEDs) that pass light through
the site to a diode (detector). Signal data is obtained by passing various visible and infrared
lights (LEDs, 500 to 1400nm) through a capillary bed (for example, a fingertip, a hand, a
foot) and measuring changes in light absorption during the blood pulsatile cycle. This
information may be useful to clinicians. The maximum radiant power of the strongest light
is rated at ≤ 25 mW. The detector receives the light, converts it into an electronic signal and
sends it to the Rad-67 for calculation.
Once Rad-67 receives the signal from the sensor, it utilizes proprietary algorithms to
calculate the patient’s functional oxygen saturation (SpO2 [%]), total hemoglobin
concentration (SpHb [g/dL]) and pulse rate (PR). The SpHb measurements rely on a multiwavelength calibration equation to quantify the percentage of carbon monoxide and
methemoglobin and the concentration of total hemoglobin in arterial blood. Maximum skinsensor interface temperature was tested to be less than 41º C (106º F) in a minimum
ambient temperature of 35º C (95º F). The tests were conducted with sensors operating at
reasonable worst case power.
www.masimo.com 22 Masimo
Rad-67 Chapter 1: Technology Overview
Pulse CO-Oximetry vs. Drawn Whole Blood Measurements
When SpO2 and SpHb measurements obtained from the Rad-67 (noninvasive) are compared
to drawn whole blood (invasive) measurements by blood gas and/or laboratory CO-Oximetry
methods, caution should be taken when evaluating and interpreting the results.
The blood gas and/or laboratory CO-Oximetry measurements may differ from the SpO2 and
SpHb measurements of the Rad-67. Any comparisons should be simultaneous, meaning the
measurement on the device should be noted at the exact time that blood is drawn.
In the case of SpO2, different results are usually obtained from the arterial blood gas sample
if the calculated measurement is not appropriately corrected for the effects of variables that
shift the relationship between the partial pressure of oxygen (pO2) and saturation, such as:
pH,temperature, the partial pressure of carbon dioxide (pCO2), 2,3-DPG, and fetal
hemoglobin.
In the case of SpHb, variation in hemoglobin measurements may be profound and may be
affected by sampling technique as well as the patient's physiological conditions. Any results
exhibiting inconsistency with the patient's clinical status should be repeated and/or
supplemented with additional test data. As with most hemoglobin tests, a laboratory blood
sample should be analyzed prior to clinical decision making.
High levels of bilirubin may cause erroneous SpO2 and SpHb readings. As blood samples are
usually taken over a period of 20 seconds (the time it takes to draw the blood) a meaningful
comparison can only be achieved if the oxygen saturation (SaO2), levels of
carboxyhemoglobin (COHb), and MetHb of the patient are stable and not changing over the
period of time that the blood gas sample is taken. Subsequently, blood gas and laboratory
CO-Oximetry measurements of SpO2 and SpHb may vary with the rapid administration of
fluids and in procedures such as dialysis. Additionally, drawn whole blood testing can be
affected by sample handling methods and time elapsed between blood draw and sample
testing.
Measurements with Low Signal IQ should not be compared to laboratory measurements.
General Description for Total Hemoglobin (SpHb)
Pulse CO-Oximetry is a continuous and noninvasive method of measuring the levels of total
hemoglobin (SpHb) in arterial blood. It relies on the same principles of pulse oximetry to
make its SpHb measurement.
Successful Monitoring for SpHb
A stable SpHb reading is associated with correct sensor placement, small physiological
changes during the measurement and acceptable levels of arterial perfusion at the
measurement site. Physiological changes at the measurement site are mainly caused by
fluctuations in the oxygen saturation, blood concentration and perfusion. See Safety Information, Warnings and Cautions on page 11 and Troubleshooting Measurements on
page 67.
General Description for Total Arterial Oxygen Content (CaO2)
Oxygen (O2) is carried in the blood in two forms, either dissolved in plasma or combined
with hemoglobin. The amount of oxygen in the arterial blood is termed the oxygen content
www.masimo.com 23 Masimo
Rad-67 Chapter 1: Technology Overview
(CaO2) and is measured in units of ml O2/dL blood. One gram of hemoglobin (Hb) can carry
1.34 ml of oxygen, whereas 100 ml of blood plasma may carry approximately 0.3 ml of
oxygen*. The oxygen content is determined mathematically as:
CaO2 = 1.34 (ml O2/g) x Hb (g/dL) x HbO2 + PaO2 (mmHg) x 0.003 (ml O2/dL/mmHg)
Where HbO2 is the fractional arterial oxygen saturation and PaO2 is the partial pressure of
arterial oxygen.
For typical PaO2 values, the second part of the above equation is approximately 0.3 ml O2/dL
based on PaO2 being approximately 100 mmHg. Furthermore, for typical carboxyhemoglobin
and methemoglobin levels, the functional saturation (SpO2) as measured by a pulse
oximeter is given by:
SpO2 = 1.02 x HbO2
*Martin, Laurence. All You Really Need to Know to Interpret Arterial Blood Gases, Second
Edition. New York: Lippincott Williams & Wilkins, 1999.
SpHb Measurements During Patient Motion
The Rad-67 displays measurements of SpHb during patient motion. However, because of the
changes in the physiological parameters such as blood volume, arterial-venous coupling,
etc. that occur during patient motion, the accuracy of such measurements may not be
reliable during excessive motion. In this case, the measurement value for SpHb displays as
dashes (---) and a message (Low SpHb SIQ) displays to alert the clinician that the device
does not have confidence in the value due to poor signal quality caused by excessive motion
or other signal interference.
www.masimo.com 24 Masimo
Chapter 2: Description
This chapter contains the description of the Rad-67 physical features.
General System Description
The Rad-67 system includes the following:
Rad-67 Device
Rad-67 AC Power Supply
Patient Cable
Sensor
For a complete list of compatible sensors and cables, visit http://www.masimo.com.
www.masimo.com 25 Masimo
Rad-67 Chapter 2: Description
1. Display and Touchscreen
Provides a user interface to view and change
settings.
2. Home Button
Provides a multipurpose user interface that
allows for navigation to the home screen as
well as turning the device on and off.
3. Patient Cable Port
Provides a connection to a patient cable.
4. Masimo Proprietary Port
Provides a connection to:
AC power supply for battery charging.
Provides data transfer and upgrade
ability using a Masimo proprietary
cable.
Note: Always connect the Rad-67 to the
mains power for continuous operation and/
or battery recharging.
Note: Unplug the Masimo Proprietary cable
to disconnect the AC power supply.
Features
Front, Top, and Bottom Views
www.masimo.com 26 Masimo
Chapter 3: Setting Up
This chapter contains information about setting up Rad-67 before use.
Unpacking and Inspection
To unpack and inspect the Rad-67:
1. Remove the Rad-67 from the shipping carton and examine it for signs of shipping
damage.
2. Check all materials against the packing list. Save all packing materials, invoice
and bill of lading. These may be required to process a claim with the carrier.
3. If anything is missing or damaged, contact the Masimo Technical Service
Department. See Return Procedure on page 95.
Preparation for Use
Prior to setting up the Rad-67 for spot-check monitoring, perform the following steps:
1. Confirm that you have all system components:
Rad-67 Device
Rad-67 AC Power Supply
Patient Cable
Sensor
2. Read the Safety Information, Warnings and Cautions on page 11.
3. Setup the Rad-67 according to the directions provided in this Operator's Manual.
Guidelines for Setting Up
When setting up Rad-67, follow these guidelines:
1. Charge Rad-67's battery fully before use. See Initial Battery Charging on page 27.
2. Rad-67 should not be used outside the environmental conditions listed in the
specifications section. See Environmental on page 79.
Initial Battery Charging
Before use, the Rad-67 battery must be charged completely.
To charge Rad-67
1. Plug the Rad-67 AC Power Supply into the device. Make sure it is securely plugged
in.
2. Plug the Rad-67 AC Power Supply into an AC power source.
3. Verify that the battery is charging:
www.masimo.com 27 Masimo
Rad-67 Chapter 3: Setting Up
When Rad-67 is ON and charging, the AC Power Indicator lightning bolt
icon appears on the screen.
When Rad-67 is OFF and charging, the Home button will illuminate Orange.
4. When the battery is fully charged and Rad-67 is ON, the AC Power Indicator
changes to a plug icon.
Touch the AC Power Indicator icon to view battery charge details. See Rad-67 Battery on
page 52. For additional information, see Battery Operation and Maintenance on page 94.
Powering the Rad-67 ON and OFF
To turn ON the Rad-67
1. Press and hold the Home Button for more than two (2) seconds, until two (2)
audible tones sound.
2. The Home Button will illuminate Green and the Rad-67 will power on.
3. Once the device in ON and a cable is connected, the spot-check operation begins.
See Chapter 5: Spot-Check on page 57 for complete information about
performing a spot-check.
Note: When powering on Rad-67 after the battery is completely discharged, the device will
prompt to enter current time and date.
To turn OFF the Rad-67
1. Press and hold the Home Button for more than 2 seconds, until two (2) audible
tones sound.
2. The Home Button will flash Orange.
3. The Rad-67 will power down and turn off.
www.masimo.com 28 Masimo
Loading...
+ 76 hidden pages
You need points to download manuals.
1 point = 1 manual.
You can buy points or you can get point for every manual you upload.